Thyrocare

Thyrocare shares jump over 11% after strong Q2 results; Approves bonus issue in 2:1 ratio

Thyrocare shares rally over 7% as Q1 net profit rises 62% YoY Rs 38.06 crore, revenue up 23% YoY

Thyrocare stock surges 12% as Q4 revenue jumps 21% YoY to Rs 187.2 crore

Thyrocare completes acquisition of Vimta Labs’ Diagnostic business

PharmEasy looks forward to acquiring 66.1% stake in Thyrocare for Rs 4,546 crore

PharmEasy for Rs 4,546 crore, plans to acquire 66.1% stake in Thyrocare.